Excessive lipid accumulation in the liver promotes the activation of Kupffer cells (KCs) and the production of inflammatory mediators (TNF-α and IL-1β, among others), leading to increased insulin resistance, liver inflammation, and the formation of the blood-brain barrier, which eventually results in the development of NASH [42]. Here, IL1B is linked to metabolic dysfunction-associated steatohepatitis.